Aliso Viejo, CA (PRWEB) June 20, 2012
RxLogix Corporation (http://www.rxlogix.com), the most experienced team of global Safety and Risk Management experts offering consulting services and strategic software solutions, today announced the general availability of its first two strategic software solutions, PV Central and clinsafety. This represents a major milestone for the company since its inception, and further confirms RxLogix’s leadership in Safety and Risk Management at a global level in providing software and services solutions for their clients. The solutions are being deployed at several companies, including a Top 5 global pharmaceutical client.
PV Central provides proactive dashboards and early warning intelligence, including compliance monitoring for Safety and PV Operations management, through an easy to use and intuitive interface including mobile platforms such as the iPhone or iPad. Enabling safety management to have real time information about key global safety metrics including productivity, risk management, and compliance readiness enables an organization to improve accountability and transparency. PV Central key features can help an organization be prepared proactively to take immediate action before significant problems arise. clinsafety was designed to improve the integration challenges of EDC based clinical trials and Safety databases, by providing a best of breed and standards based solution for integration between any EDC system and any commercial Safety database product. clinsafety was developed to not only integrate clinical to safety for AE reporting, but improve the productivity and significantly reduce the amount of reconciliation, generally a very costly and time consuming process during clinical trials. Both products are available as hosted solutions on the RxLogix SaaS platform for ease of implementation.
RxLogix’s CEO Raj More commented, “I am very pleased with RxLogix’s continued growth and customer acceptance of these key software solutions in addition to our global service capabilities. RxLogix plans to continue introducing solutions designed to improve workflow for organizations with well-established inefficiencies where RxLogix can make a significant improvement." Key elements in the successful launch of the solutions were the level of attention paid to business requirements and needs, in addition to technical architecture and brief implementation timelines. RxLogix’s Chief Strategy Officer Yusuf Shirazi stated, “Customers are reporting significant reductions in cost, as much as 80%, with clinsafety’s flexible architecture. Many customers are also impressed with the ease of setup for the clinical trials and automation out of the box.” Selected customer briefings have demonstrated the market is ready for these capabilities. RxLogix’s John Loucks, Head of Global Sales and Marketing, commented, “It is clear the Life Sciences industry is looking for expert knowledge and solutions that provide real value and cost savings. Every client who has seen the RxLogix products commented these products solve an important need and several have requested or begun evaluations at their locations.”
To arrange a demonstration with the RxLogix’s strategic software solutions, please contact Chief Sales and Marketing Officer John Loucks at 570-472-3459 or email john(dot)loucks(at)rxlogix(dot)com.
About RxLogix Corporation
RxLogix Corporation is an experienced team of global Safety and Risk Management experts offering consulting and strategic software solutions. RxLogix has extensive business, domain, regulatory, and IT experience consulting with global leading biopharmaceutical, medical device, and CRO’s. In addition, RxLogix provides strategic software solutions for executive management and key integrations that enhance client productivity while lowering costs.
With a global staff of 70+ and headquartered in Aliso Viejo, California, RxLogix has offices in the United States, Europe and Japan. To learn more about the company's products and services, please see their contact information above.